Vitamin C (Sodium Ascorbate)
Last reviewed
Vitamin C is the mandatory enzymatic cofactor for prolyl and lysyl hydroxylases, the enzymes that prepare collagen for folding and crosslinking. Hypermobile patients run 21% lower plasma levels than controls. It also supports DAO activity for histamine clearance. ZebraThrive delivers 1,500 mg vitamin C daily from 1,686 mg sodium ascorbate in the Daily Powder, gentle on mast-cell-sensitive guts.
At a Glance
Daily Dose
1,500 mg vitamin C daily from 1,686 mg sodium ascorbate, in the Daily Powder, split AM and PM scoops (per v7.8 RFQ)
Key Benefits
How It Works
Vitamin C is the single most critical supplement for connective tissue because your body cannot make stable collagen without it.
For collagen (hEDS): Vitamin C is the mandatory cofactor for prolyl and lysyl hydroxylase, the enzymes that hydroxylate proline and lysine residues on newly made collagen chains. That hydroxylation is what allows the chains to fold into a stable triple helix. Without enough vitamin C, the folding step idles and the resulting tissue is weak and fragile. The downstream crosslinking step between mature collagen molecules is performed by lysyl oxidase, a copper-dependent enzyme, and is a separate process from vitamin C's role. A 2024 Danish study found that hEDS patients have 21% lower plasma vitamin C levels than controls, suggesting they 'use up' Vitamin C faster due to high collagen turnover.
For POTS: Vitamin C reduces oxidative stress and improves the reactivity of blood vessels. One trial showed that high-dose Vitamin C helped normalize the way veins respond to position changes in certain POTS patients.
For mast cells (MCAS): Vitamin C degrades histamine directly and serves as a vital cofactor for Diamine Oxidase (DAO)-the primary enzyme responsible for breaking down histamine. It has been shown to increase DAO activity and reduce serum histamine levels by over 30%.
What the Research Shows
First direct evidence that hypermobility patients are chronically low in Vitamin C.
Danish cohort study (2024)
hEDS patients showed 21% lower levels; 32% were clinically suboptimal, suggesting higher metabolic demand.
Vitamin C doubles the body's markers for new collagen production.
Human Study (2017)
Exercise combined with Vitamin C supplementation doubled the appearance of collagen building blocks in the blood.
Significant enhancement of the body's ability to repair connective tissue at therapeutic doses.
Significant reduction in histamine levels and increase in degradation enzymes.
Direct clinical evidence of massive histamine reduction via vitamin C administration.
Human RCT
Oral doses significantly increased the activity of the enzyme responsible for clearing histamine from the gut.
Addressing the Triad
Tailored benefits for complex conditions
Vitamin C is part of standard MCAS protocols because it raises DAO activity and lowers circulating histamine (IV studies show 30% drops within hours; oral effects are slower but steady). The form choice matters more than most realize: we use sodium ascorbate because the acidic forms can irritate MCAS guts, and because the citric acid commonly used as a buffer in other vitamin C products is one of the most-reported MCAS trigger ingredients.
Vitamin C is the only nutrient with a non-negotiable role in collagen synthesis: the hydroxylase enzymes that prepare new collagen chains physically cannot work without it. Below the cofactor threshold, the enzymes idle; above it, they work at full speed. The 2024 Danish study showing roughly 6x higher rates of suboptimal vitamin C in hypermobile patients suggests this threshold issue is unusually common in our community. Vitamin C also supports TIMP-1, one of the body's natural MMP inhibitors, adding an ECM-protective angle on top of the structural role.
For POTS, vitamin C wears two hats. First, sodium ascorbate delivers about 130 mg of sodium per gram - useful when you're trying to expand blood volume anyway. Second, direct vascular effects: a controlled study in POTS patients showed IV vitamin C improved cardiac index and calf blood flow. Oral dosing can't replicate IV concentrations, but the mechanism still matters at oral levels - better endothelial function, less oxidative stress on blood vessels, and steady support for autonomic regulation. It's foundational across all three conditions in the triad.
Why We Chose This Form
We use sodium ascorbate - vitamin C buffered to roughly neutral pH - rather than acidic ascorbic acid. The acidity of plain vitamin C is a real problem for the gastroparesis and reflux common in MCAS and POTS. Sodium ascorbate sits gently, and each gram delivers about 130 mg of sodium, useful when you're already salt-loading for POTS. We dose 1,686 mg of the sodium ascorbate salt to deliver 1,500 mg of pure vitamin C - past the cofactor saturation point for collagen synthesis, well clear of the oxalate trouble zone, with the bonus sodium for blood volume.
Form Comparison
Ascorbic Acid (Corn-derived)
Highly acidic; corn-residue histamine risk; stomach set
Sodium Ascorbate (Corn-Free)
Buffered (pH 7.0); provides extra POTS sodium; corn-free
Safety & Interactions
Potential Side Effects
Excellent safety. The main effect is reaching 'bowel tolerance' (loose stools) if the dose is too high, which signifies you've exceeded your absorption limit. Our 1,500 mg daily dose sits below the 2,000 mg general upper limit and is split across the AM and PM Daily Powder scoops for tolerance.
Drug Interactions
Anticoagulants: May slightly affect vitamin K metabolism at extreme doses (rare at 1.5g). Iron supplements: Enhances iron absorption (monitor if you have iron overload like Hemochromatosis). Copper: Extremely high dose vitamin C can compete with copper; since DAO requires copper, we keep the dose at 1.5 g, well below the level where copper competition becomes a concern.
Excipients to Avoid
- Corn-derived fillers
- Synthetic dyes
- Fermentation byproducts
Safe Excipients
- Tapioca-derived ascorbate
- Sodium-buffered powder
Monitor for iron overload if you have Hemochromatosis. For men, ensure adequate hydration to mitigate any theoretical kidney stone risk associated with high-dose B-vitamins/C (though risk is not proven in women).
How to Start
| Protocol Step | Suggested Dosage | Key Notes |
|---|---|---|
| Week 1 | 250 mg twice daily | Assess GI tolerance |
| Week 2 | 500 mg twice daily | Standard titration |
| Week 3+ | 750 mg twice daily | Full target dose (1,500 mg/day, delivered in the Daily Powder split AM and PM) |
"DAO enzyme activity and histamine reduction usually improve within 2-4 weeks. Collagen synthesis support is a baseline lifestyle requirement and should be continued indefinitely."
State of the Evidence
While the 21% deficit in hEDS establishes a clear need, no randomized clinical trial has yet proven that high-dose Vitamin C reverses hypermobility symptoms. Much of the dramatic POTS cardiovascular data used IV doses that are much higher than what can be absorbed through purely oral supplementation.
- [1]hEDS patients have 21% lower plasma vitamin CPMID: 39311717
Leinøe et al. (2024)
- [2]IV vitamin C increased cardiac output 40% in POTSPMID: 21622825
Stewart et al. (2011)
- [3]7.5g IV reduced serum histamine 31%PMID: 23666445
Hagel et al. (2014)
- [4]Vitamin C + gelatin doubled collagen synthesis markersPMID: 27852613
Shaw et al. (2017)
- [5]2g oral increased DAO activityPMID: 25095772
Johnston (2015)
- [6]Kjaer et al., "1,250 mg → 49% increase in wound collagen marker"PMID: 31897483
Common Questions
Written by Ken Chapman, Founder of ZebraThrive. Reviewed and last updated .